Copy Link Print Information

Emfizatamab

(Synonyms: GNC-038)
Customer Review

Based on 1 Customer Validation

Emfizatamab (GNC-038) is a monoclonal antibody against CD19/CD3E/TNFRSF9/PD-L1. Emfizatamab exhibits antitumor activity, being capable of activating CD3 and 4-1BB signals on T cells, as well as targeting the high expression of CD19 or PD-L1 on tumor cells. Emfizatamab functions as a CD19-specific T cell engager by mediating direct antitumor activity. Emfizatamab can also overcome the inhibition of T cells by PD-L1. Emfizatamab can be used in the research of tumors such as R/R non-Hodgkin lymphoma or acute lymphoblastic leukemia.

For research use only. We do not sell to patients.

  • Purity: 95.495%
  • CAS No.: 2559704-23-1
  • Molecular Weight:303.229 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Emfizatamab Chemical Structure
    Emfizatamab Chemical Structure
CAS No.: 2559704-23-1
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Emfizatamab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

All TNF Receptor Isoforms

More

All Interleukin Related Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)

  • 1/16

    Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Emfizatamab. The EC50 for this effect is 27.4 ng/mL.

  • 1/16

    Immobilized CD19 Protein, Human (HEK293, His, HY-P74330) can bind Emfizatamab. The EC50 for this effect is 57.29 ng/mL.

  • 1/16

    Immobilized 4-1BB/TNFRSF9 Protein, Human, HY-P7125) can bind Emfizatamab. The EC50 for this effect is 1.358 ng/mL.

  • 1/16

    Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Emfizatamab. The EC50 for this effect is 64.84 ng/mL.

  • Emfizatamab Chemical Structure
    1/16
  • Emfizatamab
  • Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Emfizatamab. The EC50 for this effect is 27.4 ng/mL.
  • Immobilized CD19 Protein, Human (HEK293, His, HY-P74330) can bind Emfizatamab. The EC50 for this effect is 57.29 ng/mL.
  • Immobilized 4-1BB/TNFRSF9 Protein, Human, HY-P7125) can bind Emfizatamab. The EC50 for this effect is 1.358 ng/mL.
  • Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Emfizatamab. The EC50 for this effect is 64.84 ng/mL.
  • (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)